SG66504A1 - Pharmaceutical composition of hedgehog proteins and use thereof - Google Patents

Pharmaceutical composition of hedgehog proteins and use thereof

Info

Publication number
SG66504A1
SG66504A1 SG1999000333A SG1999000333A SG66504A1 SG 66504 A1 SG66504 A1 SG 66504A1 SG 1999000333 A SG1999000333 A SG 1999000333A SG 1999000333 A SG1999000333 A SG 1999000333A SG 66504 A1 SG66504 A1 SG 66504A1
Authority
SG
Singapore
Prior art keywords
carrier
hedgehog protein
pharmaceutical composition
hedgehog
negatively
Prior art date
Application number
SG1999000333A
Other languages
English (en)
Inventor
Kurt Lang
Apollon Papadimitriou
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of SG66504A1 publication Critical patent/SG66504A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG1999000333A 1998-02-04 1999-02-03 Pharmaceutical composition of hedgehog proteins and use thereof SG66504A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98101893 1998-02-04
EP98104416 1998-03-12

Publications (1)

Publication Number Publication Date
SG66504A1 true SG66504A1 (en) 2000-07-18

Family

ID=26149005

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1999000333A SG66504A1 (en) 1998-02-04 1999-02-03 Pharmaceutical composition of hedgehog proteins and use thereof

Country Status (14)

Country Link
JP (1) JP3092706B2 (cs)
KR (2) KR100311565B1 (cs)
CN (1) CN1228994A (cs)
AT (1) ATE331533T1 (cs)
AU (1) AU713568B2 (cs)
CA (1) CA2260423C (cs)
CZ (1) CZ33799A3 (cs)
DE (1) DE69932113T2 (cs)
HU (1) HUP9900251A3 (cs)
IL (1) IL128329A (cs)
MA (1) MA26602A1 (cs)
NO (1) NO990471L (cs)
NZ (1) NZ334065A (cs)
SG (1) SG66504A1 (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
KR100452752B1 (ko) * 2000-04-18 2004-10-12 주식회사 펩트론 단백질 함유 서방성 제제를 제조하는 방법 및 그 제제
KR101705323B1 (ko) * 2010-03-23 2017-02-13 코웨이 주식회사 역삼투막 방식의 정수기
KR102176832B1 (ko) * 2017-11-29 2020-11-10 주식회사 파이안바이오테크놀로지 헤지호그 단백질 및 생체 적합성 물질을 포함하는 미세 입자 및 이를 포함하는 탈모 예방 또는 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866165A (en) 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair

Also Published As

Publication number Publication date
DE69932113D1 (de) 2006-08-10
CN1228994A (zh) 1999-09-22
NO990471L (no) 1999-08-05
KR19990072423A (ko) 1999-09-27
IL128329A (en) 2005-08-31
KR19990072406A (ko) 1999-09-27
AU713568B2 (en) 1999-12-02
HUP9900251A3 (en) 2001-01-29
CZ33799A3 (cs) 1999-08-11
NZ334065A (en) 2000-06-23
JP2000119193A (ja) 2000-04-25
DE69932113T2 (de) 2007-01-25
HU9900251D0 (en) 1999-03-29
KR100311565B1 (ko) 2001-11-02
AU1542699A (en) 1999-08-26
CA2260423A1 (en) 1999-08-04
NO990471D0 (no) 1999-02-01
CA2260423C (en) 2006-06-20
MA26602A1 (fr) 2004-12-20
ATE331533T1 (de) 2006-07-15
JP3092706B2 (ja) 2000-09-25
IL128329A0 (en) 2000-01-31
HUP9900251A2 (hu) 1999-09-28

Similar Documents

Publication Publication Date Title
AU9036598A (en) Methods and compositions to prevent formation of adhesions in biological tissues
DE69835201D1 (en) Neoglycoproteine
CA2329768A1 (en) Pharmaceutical composition comprising factor viii and neutral liposomes
AU8700898A (en) Bioresorbable compositions for implantable prostheses
CA2173317A1 (en) Pharmaceutically acceptable polymeric tissue coating
EP2266590A3 (en) Active agent delivery sytems and methods for protecting and administering active agents
CA2239775A1 (en) Crosslinked polymer compositions and methods for their use
EP1577670A3 (en) Latent reactive polymers with biologically active moieties
TWI255721B (en) Absorbable microparticles
JP2003525916A5 (cs)
WO1995024430A3 (en) Block and graft copolymers and methods relating thereto
CA2291074A1 (en) Composition and method for enhancing transport across biological membranes
CA2244205A1 (en) Methods and compositions for enhancing the bioadhesive properties of polymers
WO1998035703A3 (en) Methods and compositions for delivery of therapeutic agents to bone tissue employing conjugates of negatively charged peptide oligomers with therapeutic agents
CA2251281A1 (en) Drug composition with controlled drug release rate
CA2286900A1 (en) Methods for actively binding heparin to cross-linked biological tissues
CA2287534A1 (en) Biodegradable microparticles for the sustained delivery of therapeutic drugs
AU7808700A (en) Zwitterionic polymer blend materials
IL128329A0 (en) Pharmaceutical composition of hedgehog proteins and use thereof
CA2283648A1 (en) Polymeric carrier
WO1996028468A3 (en) Amphiphilic peptide and analogs thereof
WO2000063366A3 (en) Improved antisense oligomers
ECSP992851A (es) Composiciones farmaceuticas de proteinas erizo y uso de las mismas
WO1996040273A3 (en) Conjugates of ferrites and oligonucleotides, which bond specifically to certain target structures
RU99101937A (ru) Фармацевтическая композиция, содержащая hedgehog-белки, и ее применение